Novartis Investigative Site

Leiden 2333 ZA, Netherlands 2333

0 studies enrolling now · 1 studies all time

What they study most

Allergic Asthma

Studies at this site

• Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists — Completed